Modulation of ICa-L by alpha1-adrenergic stimulation in rat ventricular myocytes

Can J Physiol Pharmacol. 2005 Nov;83(11):1015-24. doi: 10.1139/y05-058.

Abstract

We found when L-type calcium current (ICa-L) was recorded with the perforated patch-clamp method in rat ventricular myocytes that bath application of phenylephrine (with propranolol) evoked a biphasic response characterized by an initial transient suppression followed by a sustained potentiation. The transient suppression occurred 30-60 s after phenylephrine perfusion and reached peak inhibition at approximately 2 min. The biphasic modulation of ICa-L was also elicited by methoxamine, and the effects of phenylephrine were blocked by prazosin, indicating that the responses were mediated through alpha1-adrenoceptors. Pretreatment of cells with H7 (100 micromol/L), a broad-spectrum protein kinase inhibitor that inhibits both protein kinase C and A, eliminated potentiation but did not affect transient suppression. The transient suppression occurred concurrently with the acceleration of the fast component of ICa-L inactivation. Depletion of intracellular Ca2+ stores by ryanodine plus caffeine or thapsigargin eliminated the transient suppression. When ICa-L was recorded with whole-cell patch-clamp and with 0.05 mmol/L EGTA in the pipette solution to allow intracellular Ca2+ to fluctuate, phenylephrine evoked a transient suppression as in the perforated patch recordings. Heparin, a specific blocker of IP3 (inositol 1,4,5-trisphosphate) receptors, eliminated the phenylephrine-induced transient suppression of ICa-L when added to the pipette solution. Intensive chelation of intracellular Ca2+ by 5 mmol/L BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) in the pipette solution also eliminated the phenylephrine-induced transient suppression of ICa-L. We conclude that transient increase in the concentration of intracellular calcium ([Ca2+]i) caused by Ca2+ release from intracellular stores underlies the transient suppression of ICa-L, whereas the potentiation of ICa-L is a result of activation of protein kinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Adrenergic alpha-1 Receptor Agonists*
  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Calcium / metabolism*
  • Calcium Channels, L-Type / physiology*
  • Enzyme Inhibitors / pharmacology
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Inositol 1,4,5-Trisphosphate
  • Methoxamine / pharmacology
  • Muscle Cells / drug effects
  • Muscle Cells / physiology
  • Phenylephrine / pharmacology
  • Prazosin / pharmacology
  • Propranolol / pharmacology
  • Protein Kinase C / antagonists & inhibitors
  • Rats
  • Receptors, Adrenergic, alpha-1 / metabolism
  • Ventricular Function

Substances

  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Calcium Channels, L-Type
  • Enzyme Inhibitors
  • Receptors, Adrenergic, alpha-1
  • Phenylephrine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Inositol 1,4,5-Trisphosphate
  • Propranolol
  • Protein Kinase C
  • Methoxamine
  • Calcium
  • Prazosin